STOCK TITAN

Nu-Med Plus delays Q3 report after Avid Gold deal

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
NT 10-Q

Rhea-AI Filing Summary

Nu-Med Plus, Inc. (NUMD) says it cannot file its Form 10-Q for the quarter ended September 30, 2026, by the prescribed due date because preparation of its financial statements for review by its independent registered accounting firm was delayed following the closing of the Avid Gold transaction. The company intends to file the report on or before the fifth calendar day following the prescribed due date.

Nu-Med acquired Avid Gold on July 8, 2026, under a Share Exchange Agreement dated June 29, 2026.

Filing Explained

The completed acquisition transferred 100% of Avid Gold to Nu-Med on July 8, 2026, in exchange for 4,500,000 Series A preferred shares issuable pro rata to Avid Gold’s former shareholders and Nu-Med’s agreement to repay Avid Gold’s $100,000 promissory note.

Avid Gold interest acquired 100% Nu-Med acquired Avid Gold on July 8, 2026.
Series A Preferred Stock shares 4,500,000 shares Shares issuable to Avid Gold shareholders pro rata with their ownership of Avid Gold as acquisition consideration.
Promissory note repayment $100,000 Nu-Med agreed to repay the amount owed by Avid Gold under an outstanding promissory note.
Intended filing period 5 calendar days Nu-Med intends to file on or before the fifth calendar day following the prescribed due date.
Rule 12b-25 regulatory
"In accordance with Rule 12b-25 promulgated under the Securities Exchange Act"
Rule 12b-25 is an SEC filing provision that lets a company notify regulators and the public that it cannot file a required periodic report (like a quarterly or annual report) on time and explains the reason for the delay. For investors, the notice is a formal heads-up that financial information will arrive late—similar to a company calling to say it will be late turning in homework—so it signals increased uncertainty and may affect trading and risk assessments until the filing is available.
independent registered accounting firm financial
"for review by the registrant’s independent registered accounting firm"
An independent registered accounting firm is a third-party audit firm, usually a certified public accounting (CPA) practice, that is officially registered with the relevant regulator to perform audits of a public company's financial statements and controls. Like an impartial inspector checking a building's safety, it examines and certifies that a company’s financial records are accurate and comply with accounting rules, which helps investors trust the numbers reported by the company.
Share Exchange Agreement financial
"that certain Share Exchange Agreement dated June 29, 2026"
A share exchange agreement is a legal deal where shareholders trade their shares in one company for shares in another, commonly used in mergers, acquisitions or corporate reorganizations. Think of it like swapping ownership cards in a game: the swap can change who controls the business, how many shares each person owns, and the value and liquidity of those holdings, so investors need to understand the exchange ratio, potential dilution and long-term impact on value and voting power.
Series A Preferred Stock financial
"4,500,000 shares of the Series A Preferred Stock of the Company"
Series A preferred stock is a type of ownership share in a company that gives investors certain advantages, such as priority in receiving profits or getting their money back if the company is sold or goes bankrupt. It is often issued during early funding stages to attract investors by offering more security than common shares. This stock matters to investors because it provides a safer way to invest while still holding potential for future gains.
promissory note financial
"$100,000 owed by Avid Gold under an outstanding promissory note"
A promissory note is a written IOU in which one party promises to pay a specific sum, often with interest, to another party by a set date or on demand. Investors care because it functions like a loan: it creates a legal claim on future cash flows, carries credit and timing risk, and can affect valuation or liquidity—think of it as a formal, tradable promise to be repaid that can be assessed like any other debt investment.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why is NUMD's September 2026 10-Q late?

Nu-Med says preparation of its financial statements for review by its independent registered accounting firm was delayed as a result of closing the Avid Gold transaction. The report covers the quarter ended September 30, 2026.

When does NUMD intend to file its late 10-Q?

Nu-Med intends to file the report on or before the fifth calendar day following the prescribed due date.

What consideration was included in NUMD's Avid Gold acquisition?

Nu-Med acquired 100% of Avid Gold on July 8, 2026. Consideration included 4,500,000 Series A Preferred Stock shares issuable pro rata to Avid Gold shareholders and an agreement to repay $100,000 owed by Avid Gold under an outstanding promissory note.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

  FORM 12b-25  

SEC File Number

000-54808

       
  NOTIFICATION OF LATE FILING   CUSIP Number
      67021R104

 

(Check One):

☐ Form 10-K ☐ Form 20-F ☐ Form 11-K

☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR

 

  For period ended: September 30, 2026

 

  ☐ Transition Report on Form 10-K
  ☐ Transition Report on Form 20-F
  ☐ Transition Report on Form 11-K
  ☐ Transition Report on Form 10-Q
  ☐ Transition Report on Form N-SAR

 

  For the transition period ended:  

 

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

 

PART I—REGISTRANT INFORMATION

 

Nu-Med Plus, Inc.

Full Name of Registrant

 

640 Belle Terre Building 2E

Address of Principal Executive Office (Street and Number)

 

Port Jefferson, New York 11777

City, State and Zip Code

 

 

   

 

 

PART II—RULE 12b-25(b) and (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

  (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
     
☒ (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
     
  (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III—NARRATIVE

 

State below in reasonable detail the reason why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

(Attach extra sheets if needed)

 

The registrant is unable to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 (the “Report”), by the prescribed due date, without unreasonable effort or expense, as a result of a delay in preparing the registrant’s financial statements for the quarter ended September 30, 2026, for review by the registrant’s independent registered accounting firm, as a result of the closing of the transactions contemplated by that certain Share Exchange Agreement dated June 29, 2026 by and between the Company, Avid Gold Ltd, a private limited company formed under the laws of England and Wales (“Avid Gold”), and the shareholders of Avid Gold (the “Avid Gold Shareholders”), pursuant to which on July 8, 2026, the Company acquired 100% of Avid Gold in exchange (a) 4,500,000 shares of the Series A Preferred Stock of the Company, issuable to the Avid Gold Shareholders pro-rata with the Avid Gold Shareholders’ ownership of Avid Gold; and (b) the agreement by the Company to repay $100,000 owed by Avid Gold under an outstanding promissory note.

 

The Company is working diligently to complete the preparation of such financial statements for review by its independent auditing firm. In accordance with Rule 12b-25 promulgated under the Securities Exchange Act of 1934, as amended, the registrant intends to file the Report on or prior to the fifth (5th) calendar day following the prescribed due date.

 

PART IV—OTHER INFORMATION

 

(1) Name and telephone number of person to contact about this notification.

 

William Hayde   (631)   403-4337
(Name)   (Area Code)   (Telephone Number)

 

(2) Have all other periodic reports required under Section 13 or 15(d) or the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

 

☒ Yes ☐ No

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

 

☐ Yes ☒ No

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reason why a reasonable estimate of the results cannot be made.

 

 NU-MED PLUS, INC.

(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned heretofore duly authorized.

 

Date: November 16, 2026 By: /s/ William Hayde
    Name: William Hayde
    Title: Chief Executive Officer

 

   

Keep reading